Works by Brunner, H. G.


Results: 26
    1

    Clinical and metabolic consequences of a historic pathogenic lamin A/C founder variant.

    Published in:
    Scientific Reports, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41598-025-08495-0
    By:
    • Wong, L. Y.;
    • Torfs, T.;
    • Vanherle, S. J. V.;
    • Janssen, J.;
    • Claes, G. R. F.;
    • Stroeks, S. L. V. M.;
    • Willemars, M. M. A.;
    • Schianchi, F.;
    • Kapsokalyvas, D.;
    • Weltjens, E.;
    • Swinnen, A.;
    • Strzelecka, A.;
    • Krapels, I. P. C.;
    • Heymans, S. R. B.;
    • Glatz, J.;
    • van den Wijngaard, A.;
    • Brunner, H. G.;
    • Broers, J.;
    • Luiken, J. F. P.;
    • Hoes, M. F.
    Publication type:
    Article
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11

    CNTNAP2 gene dosage variation is associated with schizophrenia and epilepsy.

    Published in:
    Molecular Psychiatry, 2008, v. 13, n. 3, p. 261, doi. 10.1038/sj.mp.4002049
    By:
    • Friedman, J. I.;
    • Vrijenhoek, T.;
    • Markx, S.;
    • Janssen, I. M.;
    • van der Vliet, W. A.;
    • Faas, B. H. W.;
    • Knoers, N. V.;
    • Cahn, W.;
    • Kahn, R. S.;
    • Edelmann, L.;
    • Davis, K. L.;
    • Silverman, J. M.;
    • Brunner, H. G.;
    • van Kessel, A. Geurts;
    • Wijmenga, C.;
    • Ophoff, R. A.;
    • Veltman, J. A.
    Publication type:
    Article
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21

    Variation of CNV distribution in five different ethnic populations.

    Published in:
    Cytogenetic & Genome Research, 2007, v. 118, n. 1, p. 19, doi. 10.1159/000106437
    By:
    • White, S. J.;
    • Vissers, L. E. L. M.;
    • Geurts van Kessel, A.;
    • de Menezes, R. X.;
    • Kalay, E.;
    • Lehesjoki, A. E.;
    • Giordano, P. C.;
    • van de Vosse, E.;
    • Breuning, M. H.;
    • Brunner, H. G.;
    • den Dunnen, J. T.;
    • Veltman, J. A.
    Publication type:
    Article
    22
    23
    24
    25
    26